ABSTRACT
Enantioselectivity in pharmacodynamics may be due to differences in pharmacokinetics and metabolism between the two enantiomers. Each step of the pharmacokinetic pathway may discriminate between the enantiomers; that is, absorption, protein binding, metabolism, and renal clearance. It must be anticipated, that somewhere along the road the enantiomers will behave differently.
